Helvetica Chimica Acta – Vol. 90 (2007)
1333
Experimental Part
14-Aryl- or 14-Alkyl-14H-dibenzo[a,j]xanthenes 3: General Procedure: A mixture of naphthalen-2-
ol (1; 1 mmol), aldehyde 2 (0.5 mmol), and HClO4 · SiO2 (100 mg; prepared as reported [19]) was heated
at 1008. After completion of the reaction (TLC monitoring) the mixture was filtered, the filtrate
concentrated, and the residue purified by column chromatography CC (silica gel, hexane): pure 14-aryl-
or 14-alkyl-14H-dibenzo[a,j]xanthene 3.
N-[(2-Hydroxynaphthalen-1-yl)methyl]amides 5: General Procedure: A mixture of naphthalen-2-ol
(1; 1 mmol), aldehyde 2 (1 mmol), urea (4a) or an amide 4b – d (1.4 mmol), and HClO4 · SiO2 (100 mg)
was heated at 1258. After completion of the reaction (TLC monitoring), the mixture was filtered, the
filtrate concentrated, and the residue purified by CC (silica gel, 30% AcOEt/hexane): pure N-[(2-
hydroxynaphthalen-1-yl)methyl]amide 5.
The 1H-NMR (d in ppm, J in Hz) and MS (in m/z) data of some representative products are given
below.
14-(3-Nitrophenyl)-14H-dibenzo[a,j]xanthene (3e): 1H-NMR (CDCl3, 200 MHz): 8.40 (s, 1 H); 8.25
(d, J ¼ 8.0, 2 H); 7.90 – 7.70 (m, 6 H); 7.63 – 7.21 (m, 7H); 6.50 ( s, 1 H). FAB-MS: 404 ([M þ H]þ).
1
14-(4-Methylphenyl)-14H-dibenzo[a,j]xanthene (3f): H-NMR (CDCl3, 200 MHz): 8.31 (d, J ¼ 8.0,
2 H); 7.85 – 7.71 (m, 3 H); 7.60 – 7.30 (m, 9 H); 6.90 (d, J ¼ 8.0, 2 H); 6.35 (s, 1 H); 2.10 (s, 3 H). FAB-MS:
373 ([M þ H]þ).
14-(4-Methoxyphenyl)-14H-dibenzo[a,j]xanthene (3i): 1H-NMR (CDCl3, 200 MHz): 8.30 (d, J ¼ 8.0,
2 H), 7.90 – 7.70 (m, 4 H); 7.60 – 7.30 (m, 8 H); 6.62 (d, J ¼ 8.0, 2 H); 6.35 (s, 1 H); 3.60 (s, 3 H). FAB-MS:
389 ([M þ H]þ).
14-Isopropyl-14H-dibenzo[a,j]xanthene (3l): 1H-NMR (CDCl3, 200 MHz): 8.26 (d, J ¼ 8.0, 2 H);
7.90 – 7.70 (m, 4 H); 7.61 – 7.40 (m, 2 H); 7.43 – 7.32 (m, 4 H); 5.42 (d, J ¼ 7.0, 1 H); 2.28 (m, 1 H); 0.81 (d,
J ¼ 7.0, 6 H). FAB-MS: 325 ([M þ H]þ).
N-[(2-Bromophenyl)(2-hydroxynaphthalen-1-yl)methyl]urea (5na): 1H-NMR (CDCl3/(D6)DMSO,
200 MHz): 9.28 (br. s, 1 H); 8.04 (d, J ¼ 8.0, 1 H); 7.74 – 6.78 (m, 13 H); 5.22 (br. s, 2 H). FAB-MS: 371,
373 ([M þ H]þ).
N-[(2-Hydroxynaphthalen-1-yl)(4-hydroxyphenyl)methyl]acetamide (5hb): 1H-NMR (CDCl3/
(D6)DMSO, 200 MHz): 9.64 (br. s, 1 H); 8.72 (br. s, 1 H); 8.14 (d, J ¼ 8.0, 1 H); 8.01 (d, J ¼ 8.0, 1 H);
7.42 – 6.98 (m, 8 H); 6.62 (d, J ¼ 8.0, 2 H); 2.04 (s, 3 H). FAB-MS: 296 ([M þ H]þ).
N-[(2-Hydroxynaphthalen-1-yl)naphthalen-1-ylmethyl]benzamide (5oc): 1H-NMR (CDCl3/
(D6)DMSO, 200 MHz): 10.01 (br. s, 1 H); 8.97( d, J ¼ 8.0, 1 H); 8.24 (d, J ¼ 8.0, 1 H); 7.98 – 7.16 (m,
18 H). FAB-MS: 404 ([M þ H]þ).
N-[(2-Hydroxynaphthalen-1-yl)(4-methylphenyl)methyl]prop-2-enamide (5fd): 1H-NMR (CDCl3/
(D6)DMSO, 200 MHz): 9.62 (br. s, 1 H); 8.25 (d, J ¼ 8.0, 1 H); 8.00 (d, J ¼ 8.0, 1 H); 7.78 – 7.62 (m, 2 H);
7.39 (t, J ¼ 8.0, 1 H); 7.28 – 6.90 (m, 10 H); 6.36 – 6.22 (m, 2 H); 5.61 (m, 1 H); 2.12 (s, 3 H). FAB-MS: 318
([M þ H]þ).
REFERENCES
[1] J. P. Poupelin, G. Saint-Ruft, O. Foussard-Blanpin, G. Narcisse, G. Uchida-Ernouf, R. Lacroix, Eur. J.
Med. Chem. 1978, 13, 67 .
[2] R. W. Lambert, J. A. Martin, J. H. Merrett, K. E. B. Parkes, G. J. Thomas, PCT Int. Appl. WO
9706178, 1997 (Chem. Abstr. 1997, 126, 212377y).
[3] T. Hideo, Jpn. Tokkyo koho JP 56005480, 1981 (Chem. Abstr. 1981, 95, 80922b).
[4] R. M. Ion, D. Frackowiak, A. Planner, K. Wiktorowicz, Acta Biochim. Pol. 1998, 45, 833.
[5] G. Saint-Ruf, A. De, H. T. Hieu, Bull. Chim. Ther. 1972, 7, 83; G. Saint-Ruf, H. T. Hieu, J. P.
Poupelin, Naturwissenschaften 1975, 62, 584.
[6] A. Banerjee, A. K. Mukherjee, Stain Technol. 1981, 56, 83; S. M. Menchen, S. C. Benson, J. Y. L.
Lam, W. Zhen, D. Sun, B. B. Rosenblum, S. Khan, M. Taing, U.S. Pat. 6,583,168, 2003 (Chem. Abstr.
2003, 139, 54287f).
[7] C. G. Knight, T. Stephens, Biochem. J. 1989, 258, 683.